Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular endothelial growth factor C (VEGF-C) is a secreted glycoprotein and a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. It is the primary ligand for the receptor tyrosine kinase VEGFR-3 (Flt4) and also binds to VEGFR-2 (KDR) after proteolytic processing [UniProt: P49767]. The fundamental biological role of VEGF-C is the regulation of lymphangiogenesis, the process by which new lymphatic vessels form from pre-existing ones, which is essential for fluid homeostasis and immune surveillance. In oncology, VEGF-C is frequently upregulated by various tumors, where it promotes the expansion of the lymphatic network, thereby facilitating the metastatic spread of cancer cells to regional lymph nodes. Consequently, VEGF-C is a significant therapeutic target; inhibitors such as monoclonal antibodies (e.g., VGX-100) and decoy receptors (e.g., OPT-302) are being developed to block its signaling pathways to treat metastatic cancer and ocular diseases like age-related macular degeneration [: NCT01446146, NCT03345069]. Beyond its role in vessel growth, VEGF-C is also involved in modulating inflammatory responses and has been explored for its potential pro-lymphangiogenic effects in treating lymphedema.
Neutralization of VEGF-C protein, inhibition of VEGFR-3 and VEGFR-2 activation, and decoy receptor binding (trap mechanism).
1 more in the full profile.
Source types: Peer-reviewed publication · Trial registry. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular endothelial growth factor C (VEGF-C) (VEGF-C).